← SynDRA
RETASPIMYCIN
SynDRA canonical compound SYN0022835 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HSP90AA1 |
|---|
| Mechanism of action | HSP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
- HSP inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Retaspimycine
- Retaspimicina
- IPI-504
- UNII-BZF2ZM0I5Z
- BZF2ZM0I5Z
- CHEBI:71975
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-2-azabicyclo[1631]docosa-1(22),4,6,10,18,20-hexaen-9-yl carbamate
- Retaspimycin [USAN:INN]
- Retaspimycin (USAN/INN)
- SCHEMBL13199500
- CHEMBL1184904
- SCHEMBL12251507
- ZINC43128334
- AN-27116
- D09375
- Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-
- 17 AAGH2
- retaspimycinum
- RefChem:879479
- DTXCID401511410
- Retaspimycin [USAN]
- RETASPIMYCIN [MI]
- RETASPIMYCIN [INN]
- RETASPIMYCIN [WHO-DD]
- BRD-K67935717-003-01-0
- BRD-K67935717-003-02-8
- IPI-504 HYDROCHLORIDE
- EX-A11084
- retaspimycin monohydrochloride
- UNII-928Q33Q049
- GLXC-15919
- Retaspimycin hydrochloride (USAN)
- OIRUWDYJGMHDHJ-AFXVCOSJSA-N
- Retaspimycin hydrochloride [USAN]
- D09376
- Retaspimycin (Hydrochloride)
- Retaspimycin Hydrochloride
- CHEBI:71956
Look up RETASPIMYCIN in the interactive SynDRA portal →